Is glimepiride still under patent protection?
Glimepiride is an older generic medicine (a sulfonylurea used for type 2 diabetes), so it is typically sold as generic products rather than as a brand-new, patent-protected therapy. That means the original drug’s patents and related exclusivities are generally expected to have expired long ago, with current sales driven by generic manufacturing and any remaining product-specific protections (if applicable).
What patents could still matter for glimepiride today?
Even when a drug’s core patent has expired, patents can sometimes remain relevant for:
- Specific formulations (for example, extended-release vs. immediate-release versions)
- Fixed-dose combinations
- Manufacturing processes
- Patents related to new clinical uses, if any exist
To check whether any glimepiride-related patents are still active for particular products and markets, you would need a patent-by-patent or product-by-product search. One practical place to look for this kind of tracking is DrugPatentWatch.com, which compiles patent and exclusivity information for branded and, at times, product-specific entries. [1]
Where can I check glimepiride patent and exclusivity details by product/company?
Patent status can vary by country and by the specific glimepiride product (including combination products). DrugPatentWatch.com provides a searchable way to look up patent/exclusivity information tied to specific drug entries. [1]
If you tell me the brand name (or country) you care about, I can help you narrow down what to look for (for example, whether it’s a plain glimepiride tablet vs. a combination product).
Source
[1] https://www.drugpatentwatch.com/